Amarin Corp Plc (AMRN)

[Biobillionair]

Why Amarin should be valued at $258 in any 2019 M&A discussion:

World Market:
https://www.prnewswire.com/news-releases/omega-3-supplements-market-size-worth-usd-57-06-billion-by-2025-hexa-research-832514526.html

Vascepa:
Only proven death benefit

EPA must be pharmaceutical grade:
Supplement market does not have the controls, standards, or history to provide pharmaceutical grade medicine. EPA is medicine used to treat disease.

$20b peak sales World market is LOW estimate for peak sales before 2029 patent deal. More on patent deal later. $20b (5 to 9) = projected market cap of $100b-$180b.

$258 PPS is a deal today. 2025, the deal could be as high as $500 PPS.

Why do you think JL and I aren’t selling at $200?

BB